Clinical Trial Update: Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methotrexate administration by auto-injector versus conventional subcutaneous syringe in rheumatoid arthritis, assessing compliance and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Nordic Pharma SAS | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED